Precipio Inc (PRPO) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $24.29
• Market Cap: $31.61M
• EPS: $-1.19
• 52-Week High: $28.50
• 52-Week Low: $3.90

Market Sentiment

Precipio Inc currently has a Bullish sentiment score of 0.52.

About Precipio Inc

Precipio, Inc. is a leading oncology diagnostics and reagent technology company headquartered in New Haven, Connecticut, dedicated to revolutionizing cancer diagnosis and enhancing patient outcomes. The company leverages cutting-edge technologies to deliver a comprehensive suite of diagnostic products and services tailored for healthcare providers in the U.S. oncology market. With a strong commitment to precision medicine, Precipio stands at the forefront of improving treatment selection and ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Precipio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PRPO pay dividends?

Precipio Inc (PRPO) does not currently pay a regular dividend.

What is PRPO's market cap?

Precipio Inc (PRPO) has a market capitalization of $31.61M with a current stock price of $24.29.